veto-pharma / Véto-pharma -

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/

Meta Tags

Title	Véto-pharma -
Description	Plus de 25 ans d’engagements pour Véto-pharma est un laboratoire français spécialisé dans la santé de l’abeille. Découvrez nos solutions pour combattre le varroa et le frelon
Keywords	N/A

Server Information

WebSite	veto-pharma.fr
Host IP	213.186.33.40
Location	France

Related Websites

                        Site
                        Rank
                    

More to Explore

vfsic.com

vijayahospitalvzm.com

xenonautomotive.co.uk

bigplayerclothing.com

edward-thomas-fellowship.org.uk

pleasurecontrol.org

bolly2tolly.biz

haydengarfield.com

veto-pharma.fr Valuation

US$309,035

Last updated: 2022-11-22 01:37:19

veto-pharma.fr has Semrush global rank of 34,249,574. veto-pharma.fr has an estimated worth of US$ 309,035, based on its estimated Ads revenue. veto-pharma.fr receives approximately 35,658 unique visitors each day. Its web server is located in France, with IP address 213.186.33.40. According to SiteAdvisor, veto-pharma.fr is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$309,035
Daily Ads Revenue	US$286
Monthly Ads Revenue	US$8,558
Yearly Ads Revenue	US$102,695
Daily Unique Visitors	2,378
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
veto-pharma.fr.	A	10800	IP: 213.186.33.40
veto-pharma.fr.	NS	10800	NS Record: b.dns.gandi.net.
veto-pharma.fr.	NS	10800	NS Record: a.dns.gandi.net.
veto-pharma.fr.	NS	10800	NS Record: c.dns.gandi.net.
veto-pharma.fr.	MX	10800	MX Record: 50 fb.mail.gandi.net.
veto-pharma.fr.	MX	10800	MX Record: 10 spool.mail.gandi.net.
veto-pharma.fr.	TXT	10800	TXT Record: google-site-verification=bEU3IJda07Mllr6RNFWFfzAmp2-yO-Qcah3wIixW6a8
veto-pharma.fr.	TXT	10800	TXT Record: facebook-domain-verification=75op2i5wafavlb1owvdjf6n40b2185

HtmlToTextCheckTime:2022-11-22 01:37:19

Aller au contenu FAQ Librairie Distributeurs Blog Newsletter France Ouvrir le menu Europe Espagne Amérique du Nord Menu Fermer Solutions Ouvrir le menu Varroa : ennemi public n°1 Varroa : suivi d’infestation Varroa : stratégie de traitement Frelon asiatique Produits Ouvrir le menu Apivar Oxybee Varroa EasyCheck VespaCatch Innovation Véto-pharma Ouvrir le menu Qui sommes-nous ? Nos 6 valeurs clés Engagés pour l’apiculture Contact Apicultrice Concours photo “Valorisons l’abeille et l’apiculture” 2022 Pour cette 4ème édition l’EVA - Véto-pharma, lance un concours photo. Le thème 2022 : L’apiculteur / apicultrice en sujet principal en activité au rucher ou en miellerie (extraction, conditionnement, autres…). Règlement Slide 1 Aider les apiculteurs à lutter contre Varroa Varroa destructor est le plus important prédateur de l’abeille domestique et sévit dans la quasi-totalité des pays du monde. La mise en œuvre d’une lutte intégrée contre ce parasite est d’une importance majeure et permet

HTTP Headers

HTTP/1.1 301 Moved Permanently
date: Fri, 10 Jun 2022 06:12:39 GMT
content-type: text/html; charset=UTF-8
server: Apache
x-powered-by: PHP/7.4
vary: Accept-Encoding,Cookie
x-pingback: http://www.veto-pharma.fr/xmlrpc.php
expires: Fri, 10 Jun 2022 07:12:38 GMT
cache-control: max-age=3600
x-redirect-by: WordPress
location: https://veto-pharma.fr/
x-iplb-request-id: 416C4831:B62E_D5BA2128:0050_62A2E0D5_2148B:FB08
x-iplb-instance: 29691

HTTP/2 301 
date: Fri, 10 Jun 2022 06:12:39 GMT
content-type: text/html; charset=UTF-8
server: Apache
x-powered-by: PHP/7.4
vary: Accept-Encoding,Cookie
x-pingback: https://www.veto-pharma.fr/xmlrpc.php
expires: Fri, 10 Jun 2022 07:12:38 GMT
cache-control: max-age=3600
x-redirect-by: WordPress
location: https://www.veto-pharma.fr/

HTTP/2 200 
date: Fri, 10 Jun 2022 06:12:39 GMT
content-type: text/html; charset=UTF-8
server: Apache
x-powered-by: PHP/7.4
vary: Accept-Encoding,Cookie
x-pingback: https://www.veto-pharma.fr/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink

veto-pharma.fr Whois Information

domain:      veto-pharma.fr
status:      ACTIVE
hold:        NO
holder-c:    V1157-FRNIC
admin-c:     V1157-FRNIC
tech-c:      G768-FRNIC
zone-c:      NFC1-FRNIC
nsl-id:      NSL33187-FRNIC
registrar:   GANDI
Expiry Date: 2022-07-25T13:39:57Z
created:     2014-07-25T13:39:57Z
last-update: 2022-04-29T04:11:02Z
source:      FRNIC
ns-list:     NSL33187-FRNIC
nserver:     b.dns.gandi.net
nserver:     a.dns.gandi.net
nserver:     c.dns.gandi.net
source:      FRNIC
registrar:   GANDI
type:        Isp Option 1
address:     63-65 boulevard Massena
address:     75013 PARIS
country:     FR
phone:       +33 1 70 37 76 61
fax-no:      +33 1 43 73 18 51
e-mail:      support@support.gandi.net
website:     https://www.gandi.net/fr/tlds/fr/
anonymous:   NO
registered:  2004-03-09T12:00:00Z
source:      FRNIC
nic-hdl:     V1157-FRNIC
type:        ORGANIZATION
contact:     VETO-PHARMA
address:     Vétopharma
address:     12-14 rue de la Croix Martre
address:     91120 Palaiseau
country:     FR
phone:       +33.169188480
fax-no:      +33.169281293
e-mail:      8a7a92afec09e9fabffc5cb7d1616100-1160531@contact.gandi.net
registrar:   GANDI
anonymous:   NO
obsoleted:   NO
eligstatus:  not identified
reachstatus: not identified
source:      FRNIC
nic-hdl:     V1157-FRNIC
type:        ORGANIZATION
contact:     VETO-PHARMA
address:     Vétopharma
address:     12-14 rue de la Croix Martre
address:     91120 Palaiseau
country:     FR
phone:       +33.169188480
fax-no:      +33.169281293
e-mail:      8a7a92afec09e9fabffc5cb7d1616100-1160531@contact.gandi.net
registrar:   GANDI
anonymous:   NO
obsoleted:   NO
eligstatus:  not identified
reachstatus: not identified
source:      FRNIC
nic-hdl:     G768-FRNIC
type:        ORGANIZATION
contact:     GANDI
address:     GANDI
address:     63-65 Boulevard MASSENA
address:     75013 Paris
country:     FR
phone:       +33.143737851
fax-no:      +33.143731851
e-mail:      noc@gandi.net
registrar:   GANDI
anonymous:   NO
obsoleted:   NO
eligstatus:  not identified
reachstatus: not identified
source:      FRNIC

veto-pharma.fr valuation and analysis